Author Question: Suppose that a mutation alters the formation of a tRNA such that it still attach (Read 623 times)

Yolanda

  • Hero Member
  • *****
  • Posts: 757
Suppose that a mutation alters the formation of a tRNA such that it still attaches to the same amino acid (phe) but its anticodon loop has the sequence AAU that binds to the mRNA codon UUA (that usually specifies leucine leu).
A) The modified tRNA will cause this mRNA to make only nonfunctioning product.
B) The tRNA-leu will not be able to enter the site of the ribosome to bind to the UUA.
C) One mutated tRNA molecule will be relatively inconsequential because it will compete with many "normal" ones.
D) The tRNA will be so unstable that it will not participate in translation.
E) The mutated tRNA will result in an amino acid variant in all copies of the protein.



coco

  • Hero Member
  • *****
  • Posts: 739

Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

Yolanda

  • Hero Member
  • *****
  • Posts: 757

 

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library